GLP1 Agonist Exposure in Pregnancy
Dr. Chapa’s Clinical Pearls.
00:00
Safety of GLP1 Medications in Pregnancy
The chapter examines the safety and efficacy of GLP1 medications, such as semaglutide and loraglutide, during pregnancy based on recent studies and case reports. It discusses the potential risks of using these medications in pregnant patients with type 2 diabetes, emphasizing the importance of caution and informed decision-making due to limited data on safety outcomes. The episode delves into the impact of GLP1 receptor agonists, SGLT2 inhibitors, and insulin on fetal development, highlighting the need for further research and patient education regarding non-insulin second-line diabetic medications during pregnancy and lactation.
Transcript
Play full episode
